Skip to main content
. 2019 Sep 28;394(10204):1159–1168. doi: 10.1016/S0140-6736(19)31709-X

Figure 5.

Figure 5

Tumour characteristics: relative risks during years 5–14 of current use

Fully adjusted relative risks for current versus never users during years 5–14 (mean: year 9) of use. MHT=menopausal hormone therapy.